Streptozotocin induced activation of oxidative stress responsive splenic cell signaling pathways: Protective role of arjunolic acid

Toxicology and Applied Pharmacology

Volumn 244, Issue 2, 2010, Pages 114-129

  Manna, Prasenjit ^a   Ghosh, Jyotirmoy ^a   Das, Joydeep ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Apoptosis; Arjunolic acid; Chemoprevention; Cytokines; Hyperglycemia; MAPKs; Spleen; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ARJUNOLIC ACID; CASPASE 3; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C; CYTOKINE; GAMMA INTERFERON; GLUCOSE; GLUTATHIONE DISULFIDE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; I KAPPA B ALPHA; IMMUNOMODULATING AGENT; INTERLEUKIN 2; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SAPONIN; STREPTOZOCIN; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARBONYLATION; CELL ISOLATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPLEEN; SPLEEN CELL;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; MALE; OXIDATIVE STRESS; PLANT BARK; PLANT EXTRACTS; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SPLEEN; STREPTOZOCIN; TERMINALIA; TRITERPENES;

ANIMALIA;

EID: 77950052431     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.12.024     Document Type: Article

References (69)

1. Adrain C., Creagh E.M., Martin S.J. Apoptosis-associated release of Smac/DIABLO from mitochondria requires active caspases and is blocked by Bcl-2. EMBO J. 2001, 20:6627-6636.
2. Akira S., Kishimoto T. NF-IL6 and NF-kB in cytokine gene regulation. Adv. Immunol. 1997, 65:1-46.
3. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14:649-683.
4. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40:405-412.
5. Beda N., Nedospasov A. A spectrophotometric assay for nitrate in an excess of nitrite. Nitric Oxide 2005, 13:93-97.
6. Bhakuni R.S., Shukla Y.N., Tripathi A.K., Prajapati V., Kumar S. Insect growth inhibitor activity of arjunolic acid isolated from Cornus capitata. Phytother. Res. 2002, 16:68-70.
7. Bonaventura J., Schroeder W.A., Fang S. Human erythrocyte catalase: an improved method of isolation and a revaluation of reported properties. Arch. Biochem. Biophys. 1972, 150:606-617.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Braun B., Zimmermann M.B., Kretchmer N. Effects of exercise intensity on insulin sensitivity in women with non-insulin-dependent diabetes mellitus. J. Appl. Physiol. 1995, 78:300-306.
10. Castrillo A., de Las Heras B., Hortelano S., Rodriguez B., Villar A., Bosca L. Inhibition of the nuclear factor kappa B (NF-kappa B) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-kappa B-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem. 2001, 276:15854-15860.
11. Chang F.Y., Shaio M.F. Decreased cell-mediated immunity in patients with noninsulin dependent diabetes mellitus. Diabetes Res. Clin. Pract. 1999, 528:137-146.
12. Crutcher J.M., Stevenson M.M., Sedegah M., Hoffman S.L. Interleukin-12 and malaria. Res. Immunol. 1995, 146:552-559.
13. Dezfulian C., Raat N., Shiva S., Gladwin M.T. Role of the anion nitrite in ischemia-reperfusion cytoprotection and therapeutics. Cardiovas. Res. 2007, 75:327-338.
14. Dias A.S., Porawski M., Alonso M., Marroni N., Collado P.S., Gonzalez-Gallego J. Quercetin decreases oxidative stress, NF-κB activation, and iNOS: overexpression in liver of streptozotocin-induced diabetic rats. J. Nutr. 2005, 135:2299-2304.
15. Djoukeng J.D., Abou-Mansour E., Tabacchi R., Tapondjou A.L., Bouda H., Lontsi D. Antibacterial triterpenes from Syzygium guineense (Myrtaceae). J. Ethnopharmacol. 2005, 101:283-286.
16. Doolan D.S., Hoffman S.L. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model. J. Immunol. 1999, 163:844-892.
17. Edmondson J.M., Armstrong S.L., Martinez A.O. A rapid and simple MTT based spectrophotometric assay for determining drug sensitivity in monolayer cultures. Methods Cell Sci. 1988, 11:15-17.
18. Ellman G.L. Tissue sulfhydryl group. Arch. Biochem. Biophys. 1959, 82:70-77.
19. Elsner M., Guldbakke B., Tiedge M., Mundy R., Lenzen S. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 2000, 43:1528-1533.
20. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 1990, 186:407-421.
21. Filosto M., Tonin P., Vattemi G., Savio C., Rizzuto N., Tomelleri G. Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mitochondrial diseases. Neuropathol. Appl. Neurobiol. 2003, 29:52-59.
22. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., Gross R.W., Kelly D.P. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. Proc. Natl. Acad Sci. U.S.A. 2003, 100:1226-1231.
23. Flohe L., Gunzler W.A. Assay of glutathione peroxidase. Methods Enzymol. 1984, 105:114-121.
24. Geerlings S.E., Hoepelman A.I. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol. Med. Microbiol. 1999, 26:259-265.
25. Gottenberg J.E., Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie 2007, 89:856-871.
26. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
27. Herold K.C., Vezys V., Sun Q., Viktora D., Seung E., Reiner S., Brown D.R. Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin. J. Immunol. 1996, 156:3521-3527.
28. Hodarnau A., Dancea S., Barzu O. Isolation of highly purified mitochondria from rat pancreas. J. Cell. Biol. 1973, 59:222-227.
29. Hsu T.C., Young M.R., Cmarik J., Colburn N.H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Rad. Biol. Med. 2000, 28:1338-1348.
30. Jang S.M., Yee S.T., Choi J., Choi M.S., Do G.M., Jeon S.M., Yeo J., Kim M.J., Seo K.I., Lee M.K. Ursolic acid enhances the cellular immune system and pancreatic â-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. Int. Immunopharmacol. 2009, 9:113-119.
31. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Ind. J. Biochem. Biophys. 1984, 21:130-132.
32. Kapahi P., Takahashi T., Natoli G., Adams S.R., Chen Y., Tsien R.Y., Karin M. Inhibition of NF-kappa B activation by arsenite through reaction with a critical cysteine in the activation loop of Ikappa B kinase. J. Biol. Chem. 2000, 275:36062-36066.
33. Keeble J.A., Gilmore A.P. Apoptosis commitment-translating survival signals into decisions on mitochondria. Cell Res. 2007, 17:976-984.
34. Kefaloyianni E., Gaitanaki C., Beis I. ERK1/2 and p38-MAPK signaling pathways, through MSK1, are involved in NF-κB transactivation during oxidative stress in skeletal myoblasts. Cell Signal 2006, 18:2238-2251.
35. Kim J.D., McCarter R.J.M., Yu B.P. Influence of age, exercise and dietary restriction on oxidative stress in rats. Aging. Clin. Exp. Res. 1996, 8:123-129.
36. Kim J.O., Lee G.D., Kwon J.H., Kim K.S. Anti-diabetic effects of new herbal formula in neonatally streptozotocin-induced diabetic rats. Biol. Pharm. Bull. 2009, 32:421-426.
37. Klaunig J.E., Kamendulis L.M. The role of oxidative stress in carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 2004, 44:239-267.
38. Kolb H. Benign versus destructive insulitis. Diabetes Metab. Rev. 1997, 13:139-146.
39. Konrad P., Forsgren A., Husberg B.S., Nilsson L. The immunosuppressive effect of streptozotocin-induced diabetes in rats. Res. Exp. Med. 1986, 186:455-462.
40. Kroncke K.D., Fehsel K., Sommer A., Rodriguez M.L., Kolb-Bachofen V. Nitric oxide generation during cellular metabolization of the diabetogenic N-methyl-N-nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol. Chem. Hoppe-Seyler. 1995, 376:179-185.
41. Lau J., Börjesson A., Holstad M., Sandler S. Prolactin regulation of the expression of TNF-alpha, IFN-gamma and IL-10 by splenocytes in murine multiple low dose streptozotocin diabetes. Immunol. Lett. 2006, 102:25-30.
42. LeBel C.P., Bondy S.C. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 1990, 17:435-440.
43. Mandrup-Poulsen T., Bendtzen K., Nielsen J.H., Bendixen G., Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 1985, 40:424-429.
44. Manna P., Sinha M., Sil P.C. Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes. Chem. Biol. Interact. 2007, 170:187-200.
45. Manna P., Sinha M., Sil P.C. Protection of arsenic-induced hepatic disorder by arjunolic acid. Basic Clin. Pharmacol. Toxicol. 2007, 101:333-338.
46. Manna P., Sinha M., Sil P.C. Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways. Toxicology 2009, 257:53-63.
47. Masoko P., Mdee L.K., Mampuru L.J., Eloff J.N. Biological activity of two related triterpenes isolated from Combretum nelsonii (Combretaceae) leaves. Nat. Prod. Res. 2008, 22:1074-1084.
48. Mingatto F.E., Rodrigues T., Pigoso A.A., Uyemura S.A., Curti C., Santos A.C. The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes. J. Pharmacol. Exp. Ther. 2002, 303:601-607.
49. Nishikimi M., Rao N.A., Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun. 1972, 46:849-854.
50. Nogichi H. Stem cells for the treatment of diabetes. Endocr. J. 2007, 54:7-16.
51. Oberley L.W. Free radicals and diabetes. Free Rad. Biol. Med. 1988, 5:113-124.
52. Rabinovitch A. An update on cytokines in the pathogenesis of insulin dependent diabetes mellitus. Diabetes Metab. Rev. 1998, 14:129-151.
53. Rakieten N., Rakieten M.L., Nadkarni M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 1963, 29:91-98.
54. Sakurai H., Suzuki S., Kawasaki N., Nakano H., Okazaki T., Chino A., Doi T., Saiki I. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J. Biol. Chem. 2003, 278:36916-36923.
55. Sedlak J., Lindsay R.H. Estimation of total, protein-bound, and non protein sulfhydryl groups in tissue with Ellman's reagent. Anal. Biochem. 1958, 24/25:192-205.
56. Singh N., Anand S. Cell death by apoptosis. Indian J. Exp. Biol. 1994, 32:843-847.
57. Smith I.K., Vierheller T.L., Thorne C.A. Assay of glutathione reductase in crude tissue homogenates using 5,5'-dithiobis (2-nitrobenzoic acid). Anal. Biochem. 1988, 175:408-413.
58. Tabatabaie T., Vasquez-Weldon A., Moore D.R., Kotake Y. Free radicals and the pathogenesis of type 1 diabetes: Β-cell cytokine-mediated free radical generation via cyclooxygenase-2. Diabetes 2003, 52:1994-1999.
59. Thorvaldson L., Holstad M., Sandler S. Cytokine release by mueine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNFa transcriptional inhibitor. Int. Immunopharmacol. 2003, 3:1609-1617.
60. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995, 3:251-276.
61. Turk J., Corbett J.A., Ramanandham S., Bohrer A., McDaniel M.L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 1993, 197:1458-1464.
62. Uchida K., Stadtman E.R. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 1993, 268:6388-6393.
63. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis, flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled Annexin V. J. Immunol. Methods 1995, 184:39-45.
64. Vermeulen L., De Wilde G., Van Damme P., Vanden Berghe W., Haegernan G. Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress activated protein kinase-1 (MSK1). EMBO J. 2003, 22:1313-1324.
65. Wang J., Wang G., Ansari G.A.S., Khan M.F. Activation of oxidative stress-responsive signaling pathways in early splenotoxic response of aniline. Toxicol. Appl. Pharmacol. 2008, 230:227-234.
66. Xiao SY, Zhang H, Guzman H, Tesh R Experimental yellow fever virus infection in the golden hamster(Mesocricetus auratus): II. Pathology. J. Infect. Dis. 2001, 183:1437-1444.
67. Yan J., Hales B.F. Activator protein-1 (AP-1) DNA binding activity is induced by hydroxyurea in organogenesis stage mouse embryos. Toxicol. Sci. 2005, 85:1013-1023.
68. Young H.A., Hardy K.J. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 1995, 58:373-381.
69. Zhu H., Bannenberg G.L., Moldéus P., Shertzer H.G. Oxidation pathways for the intracellular probe 2',7'-dichlorofluorescein. Arch. Toxicol. 1994, 68:582-587.